Omers Administration Corp Taro Pharmaceutical Industries LTD Transaction History

Omers Administration Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$59.35 - $88.73 $5.17 Million - $7.72 Million	-87,056 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.18 - $97.92 $3.51 Million - $4.64 Million	47,356 Added 119.28%	87,056 $7.66 Million
Q3 2019 Nov 12, 2019	BUY	$75.36 - $86.57 $685,776 - $787,786	9,100 Added 29.74%	39,700 $3 Million
Q2 2019 Aug 08, 2019	BUY	$83.92 - $108.88 $2.39 Million - $3.1 Million	28,500 Added 1357.14%	30,600 $2.65 Million
Q1 2019 May 15, 2019	BUY	$85.97 - $108.09 $180,537 - $226,989	2,100 New	2,100 $235,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

Stay updated on Omers Administration Corp with notifications on news.